COMPARE · Reviewed July 29, 2026
CI vs VEEV
Verdict: Side-by-side breakdown using the Bull Rankings model. CI scored 73.2, VEEV scored 81.9 — VEEV leads.
Compare another set
CI
The Cigna Group
73.2
$296.47 · $78.4B
fundamentals as of
Score gap
8.7
VEEV leads
VEEV
Veeva Systems Inc.
81.9
$207.91 · $33.8B
fundamentals as of
The model, pillar by pillar (0–100 each)
CI
stronger →← stronger
VEEV
59
Qualityreturns · margins · balance sheet
77
85
Growthrevenue & earnings expansion
94
78
Valuevaluation vs sector peers
75
VEEV is stronger on 2 of 3 pillars.
Fundamentals, head-to-head
CI
VEEV
$7.7bB+
FCF
$1.7bC+
+11.3%B
Rev
+16.2%B+
0.73C+
D/E
0.01A-
12.6xA
P/E
36.9xC+
0.87B+
PEG
0.88B+
Winner per row is the stronger grade in our model; a tie or a missing value shows no highlight.
Valuation · DCF cross-check
CI
VEEV
41% below
Price vs fair valuelower is cheaper
11% above
~-6%/yr
Growth the price implies10-yr FCF · lower = less priced in
~10%/yr
+54%
1-yr DCF upside
-18%
+68%
5-yr DCF upside
-10%
+92%
10-yr DCF upside
+4%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
CI
Why this score
- Raising its dividend
VEEV
No notable signals flagged.
The companies
CIThe Cigna Group
Why now
Healthcare Plans · market cap $78.4b. 6% off the 52-week high of $315.47. Revenue growing +11%, comfortably above the S&P median. PEG 0.87 — paying under fair value for the growth rate. 24 sell-side analysts publish a mean 1-yr target of $340.92 (implying +15% upside).
Moat
ROE 16% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately. FCF converts 122% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined. $78.4b market cap gives the company enough scale to absorb fixed costs that subscale competitors can't, without yet being so large that growth has to come from acquisition.
Risk
Net margin 2.3% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first.
VEEVVeeva Systems Inc.
Why now
Health Information Services · market cap $33.8b. Down 33% from 52-week high of $310.50 — deep drawdown territory. Revenue growing +16%, comfortably above the S&P median. PEG 0.88 — paying under fair value for the growth rate. 28 sell-side analysts rate this a Buy with a mean 1-yr target of $244.14 (implying +17% upside).
Moat
Net margin 28% sits well above the S&P median (~11%) — suggests structural pricing advantage or cost discipline competitors can't quickly close. ROE 13% meets the long-run market sustainable threshold — solid but not differentiated; the durability comes from elsewhere. FCF converts 177% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Down 33% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. Trailing P/E 37x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates. P/S 10.2x embeds aggressive forward growth — disappointing top-line guidance would compress the multiple hard.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.